BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33719492)

  • 1. Electroanatomic Ratios and Mortality in Patients With Heart Failure: Insights from the ASIAN-HF Registry.
    Chyou JY; Tay WT; Anand IS; Teng TK; Yap JJL; MacDonald MR; Chopra V; Loh SY; Shimizu W; Abidin IZ; ; Richards AM; Butler J; Lam CSP
    J Am Heart Assoc; 2021 Mar; 10(6):e017932. PubMed ID: 33719492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
    Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
    Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with "mid-range" QRS duration.
    Yamamoto N; Noda T; Nakano M; Ito T; Sato H; Hayashi H; Chiba T; Hasebe Y; Ueda N; Kamakura T; Ishibashi K; Miyata S; Kusano K; Yasuda S
    Heart Rhythm; 2024 Jun; 21(6):855-862. PubMed ID: 38367890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size Matters: Normalization of QRS Duration to Left Ventricular Dimension Improves Prediction of Long-Term Cardiac Resynchronization Therapy Outcome.
    Zweerink A; Friedman DJ; Klem I; van de Ven PM; Vink C; Biesbroek PS; Hansen SM; Emerek K; Kim RJ; van Rossum AC; Atwater BD; Nijveldt R; Allaart CP
    Circ Arrhythm Electrophysiol; 2018 Dec; 11(12):e006767. PubMed ID: 30541355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine Learning of 12-Lead QRS Waveforms to Identify Cardiac Resynchronization Therapy Patients With Differential Outcomes.
    Feeny AK; Rickard J; Trulock KM; Patel D; Toro S; Moennich LA; Varma N; Niebauer MJ; Gorodeski EZ; Grimm RA; Barnard J; Madabhushi A; Chung MK
    Circ Arrhythm Electrophysiol; 2020 Jul; 13(7):e008210. PubMed ID: 32538136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LBBB and heart failure-Relationships among QRS amplitude, duration, height, LV mass, and sex.
    Manne M; Niebauer M; Tchou P; Varma N
    J Cardiovasc Electrophysiol; 2024 Mar; 35(3):583-591. PubMed ID: 37811553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study.
    Gasparini M; Leclercq C; Yu CM; Auricchio A; Steinberg JS; Lamp B; Klersy C; Leyva F
    Am Heart J; 2014 Feb; 167(2):203-209.e1. PubMed ID: 24439981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry.
    MacDonald MR; Tay WT; Teng TK; Anand I; Ling LH; Yap J; Tromp J; Wander GS; Naik A; Ngarmukos T; Siswanto BB; Hung CL; Richards AM; Lam CSP; ;
    J Am Heart Assoc; 2020 Jan; 9(1):e012199. PubMed ID: 31852421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart Size Difference Drives Sex-Specific Response to Cardiac Resynchronization Therapy: A Post Hoc Analysis of the MORE-MPP CRT Trial.
    Wijesuriya N; Mehta V; De Vere F; Howell S; Niederer SA; Burri H; Sperzel J; Calo L; Thibault B; Lin W; Lee K; Grammatico A; Varma N; Gwechenberger M; Leclercq C; Rinaldi CA
    J Am Heart Assoc; 2024 Jun; 13(12):e035279. PubMed ID: 38879456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB.
    Varma N; Manne M; Nguyen D; He J; Niebauer M; Tchou P
    Heart Rhythm; 2014 Jul; 11(7):1139-47. PubMed ID: 24704570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study).
    Tan ESJ; Lim J; Chan SP; Seow JT; Singh D; Yeo WT; Lim TW; Kojodjojo P; Seow SC
    Am J Cardiol; 2019 Sep; 124(6):899-906. PubMed ID: 31326077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure.
    Gijsberts CM; Benson L; Dahlström U; Sim D; Yeo DP; Ong HY; Jaufeerally F; Leong GK; Ling LH; Richards AM; de Kleijn DP; Lund LH; Lam CS
    Heart; 2016 Sep; 102(18):1464-71. PubMed ID: 27402805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic importance of postoperative QRS widening in patients with heart failure receiving cardiac resynchronization therapy.
    Menet A; Bardet-Bouchery H; Guyomar Y; Graux P; Delelis F; Castel AL; Heuls S; Cuvelier E; Gevaert C; Ennezat PV; Tribouilloy C; Maréchaux S
    Heart Rhythm; 2016 Aug; 13(8):1636-43. PubMed ID: 27236025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
    Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.